4RS5

Crystal structure of an uncoating intermediate of a EV71 recombinant virus


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.805 Å
  • R-Value Free: 0.299 
  • R-Value Work: 0.271 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.

Lyu, K.Wang, G.C.He, Y.L.Han, J.F.Ye, Q.Qin, C.F.Chen, R.

(2015) J.Biol.Chem. 290: 3198-3208

  • DOI: 10.1074/jbc.M114.624536
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able t ...

    Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able to elicit protective responses against multiple HFMD causative agents. Previously, we have demonstrated that a thermostable recombinant EV71 vaccine candidate can be produced by the insertion of a foreign peptide into the BC loop of VP1 without affecting viral replication. Here we present crystal structures of two different naturally occurring empty particles, one from a clinical C4 strain EV71 and the other from its recombinant virus containing an insertion in the VP1 BC loop. Crystal structure analysis demonstrated that the inserted foreign peptide is well exposed on the particle surface without significant structural changes in the capsid. Importantly, such insertions do not seem to affect the virus uncoating process as illustrated by the conformational similarity between an uncoating intermediate of another recombinant virus and that of EV71. Especially, at least 18 residues from the N terminus of VP1 are transiently externalized. Altogether, our study provides insights into vaccine development against HFMD.


    Organizational Affiliation

    From the Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.,From the Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China, rongchen@ips.ac.cn.,Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and.,Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and Qiushi Academy for Advanced Studies, Zhejiang University, Hangzhou 310027, China.,Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China, and qincf@bmi.ac.cn.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Capsid protein VP3
E, N, B, H, K
242Enterovirus A71Mutation(s): 1 
Find proteins for F6KTB0 (Enterovirus A71)
Go to UniProtKB:  F6KTB0
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Capsid protein VP0
F, O, C, I, L
323Enterovirus A71Mutation(s): 0 
Find proteins for F6KTB0 (Enterovirus A71)
Go to UniProtKB:  F6KTB0
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
Capsid protein VP1
D, M, A, G, J
313Enterovirus A71Mutation(s): 0 
Find proteins for F6KTB0 (Enterovirus A71)
Go to UniProtKB:  F6KTB0
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.805 Å
  • R-Value Free: 0.299 
  • R-Value Work: 0.271 
  • Space Group: P 42 3 2
Unit Cell:
Length (Å)Angle (°)
a = 350.155α = 90.00
b = 350.155β = 90.00
c = 350.155γ = 90.00
Software Package:
Software NamePurpose
SCALEPACKdata scaling
HKL-2000data collection
PHENIXmodel building
HKL-2000data reduction
PHENIXrefinement
PHENIXphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2014-11-07 
  • Released Date: 2014-12-17 
  • Deposition Author(s): Chen, R., Lyu, K.

Revision History 

  • Version 1.0: 2014-12-17
    Type: Initial release
  • Version 1.1: 2015-04-15
    Type: Database references